Proceeds from the Offer will be used for:
• Working capital ‒ General working capital that is sufficient for ImpediMed to achieve breakeven, including advance inventory purchases to address growth, current global chip shortages, COVID-19 related supply chain issues and transition to SOZO II
• Product enhancements ‒ SOZO II development, including weight scales and improved electronics for Renal Failure and Heart Failure
• Data and software enhancements ‒ Corporate account development including electronic health record integration and heart failure programs
• Development and commercialisation of renal failure application ‒ End stage renal disease clinical trial and US FDA clearance
I'm happy with this ... glad there were no options!
- Forums
- ASX - By Stock
- Ann: Capital Raising Presentation
Proceeds from the Offer will be used for: • Working capital ‒...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
-0.001(1.23%) |
Mkt cap ! $159.8M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 7.9¢ | $23.86K | 298.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 91712 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 2376 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 91712 | 0.080 |
5 | 375067 | 0.079 |
5 | 519872 | 0.078 |
2 | 79801 | 0.077 |
4 | 73158 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 2376 | 2 |
0.081 | 45399 | 2 |
0.083 | 18000 | 1 |
0.085 | 217794 | 2 |
0.088 | 28888 | 1 |
Last trade - 15.59pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
8.0¢ |
  |
Change
-0.001 ( 1.11 %) |
|||
Open | High | Low | Volume | ||
8.0¢ | 8.1¢ | 7.9¢ | 235134 | ||
Last updated 15.59pm 07/05/2024 ? |
Featured News
IPD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online